He said the U.S. will forgo lengthy negotiations with over 170 countries and instead unilaterally impose flat tariff rates ranging between 20% and 30%. The TSX/S&P composite index rose by 0.6% at ...

ING maintains a bearish outlook on the Polish currency, suggesting the prospect of additional rate cuts will continue pressuring the PLN. The bank notes the rate differential points toward levels ...

The minutes from the CNB’s most recent monetary policy meeting, set for release Tuesday, are widely anticipated to contain hawkish messaging consistent with recent official statements. Market ...

Investing.com - BofA has reaffirmed its bearish stance on the soymeal market, maintaining its 2026 price target at $285 per ton compared to the current forward price of $308 per ton, as another market ...

Investing.com -- J.P. Morgan has resumed coverage on Drax Group (LON: DRX) with an “overweight” rating and a price target of 1,000p by December 2026, implying 46% upside from the July 3 close of 684p, ...

Investing.com - The U.K. government faces mounting fiscal challenges that will likely necessitate tax increases in the autumn ...

Investing.com -- Taiwan Semiconductor Manufacturing is postponing construction of its second plant in Japan, partly due to accelerated funding for its U.S. expansion plans ahead of potential Trump ...

This forecast marks a second consecutive year of profit contraction for the company and falls significantly below market consensus expectations. The recently announced fiscal year May 2025 fourth ...

Investing.com -- J.P. Morgan has upgraded CVC (ASX: CVC) to “overweight” from “neutral,” citing improving exit activity, a ...

Investing.com -- Britain’s construction industry downturn eased slightly in June, with homebuilding returning to growth, ...

Investing.com -- Citi Research has opened a 90-day positive catalyst watch on Continental AG (ETR: CONG ), citing a ...

Investing.com - The recent rally in Hong Kong-listed biotechs, fueled by fund flows and outlicensing expectations, has been too rapid according to investors, with focus now shifting to clinical ...